Maria Rosaria Fiore

National Center for Oncological Hadrontherapy

Papers

1

Total Citations

18

H-Index

1

About

Dr. Maria Rosaria Fiore is a leading figure in hadrontherapy, specializing in the clinical application of scanned proton and carbon ion beams for cancer treatment. Her major contribution lies in pioneering the initial clinical implementation of scanned proton beams at the Italian National Center for Hadrontherapy (CNAO), where she helped establish the first prospective Phase II protocols approved by the Italian Health Ministry. Her landmark 2013 paper, which has garnered 18 citations, reported the critical early toxicity data from CNAO’s first patients treated with this advanced technology, laying the groundwork for safer, more precise radiation therapy. Dr. Fiore’s work has been instrumental in validating the clinical feasibility and safety of scanned beams, directly impacting the adoption of hadrontherapy across Europe. Her achievements include being at the forefront of translating complex physics into tangible patient benefits, making her a key authority in the field. For students and researchers, Dr. Fiore exemplifies how rigorous clinical research can bridge engineering and oncology to improve outcomes for patients with challenging tumors, such as chondrosarcomas.

Research Focus

Key Achievements

1
H-Index
1
Papers
18
Total Citations
18
Avg Citations/Paper
🏆 Most Cited Paper
Initial clinical experience with scanned proton beams at the Italian National Center for Hadrontherapy (CNAO)
18 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: National Center for Oncological Hadrontherapy

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago